Related Experiment Video
Updated: May 12, 2026
08:41
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Genomic aspects of NAFLD pathogenesis.
Adviti Naik1, Rok Košir, Damjana Rozman
1Faculty of Computer Sciences and Informatics, Tržaška Cesta 25, Ljubljana 1000, University of Ljubljana, Slovenia.
Genomics
|April 3, 2013
Summary
Non-alcoholic fatty liver disease (NAFLD) is a global health issue, often progressing to liver cancer. Identifying reliable biomarkers for NAFLD progression remains a challenge, requiring further research into factors like circadian rhythms.
Area of Science:
- Hepatology and metabolic disease research.
Background:
- Non-alcoholic fatty liver disease (NAFLD) is the most common liver condition globally and a key feature of metabolic syndrome.
- NAFLD encompasses a spectrum from simple steatosis to non-alcoholic steatohepatitis (NASH), potentially leading to cirrhosis and hepatocellular carcinoma (HCC).
- The rising prevalence of NAFLD is linked to an increase in HCC cases.
Purpose of the Study:
- To explore the factors influencing NAFLD progression and its link to HCC.
- To discuss the potential of genetic and molecular pathways as biomarkers for NAFLD.
- To highlight the limitations in current biomarker discovery and suggest future research directions.
Main Methods:
- Review of gene expression profiling and genome-wide association studies (GWAS).
- Analysis of factors contributing to NAFLD progression, including genetics, environment, lifestyle, and metabolic syndrome.
- Consideration of emerging research areas like circadian regulation in hepatic metabolism.
Main Results:
- Gene expression and GWAS studies have identified potential pathways and genetic polymorphisms associated with NAFLD.
- The complex, multifactorial nature of NAFLD presents challenges for identifying clinically useful biomarkers.
- Current research limitations include the multifactorial etiology and insufficient powered studies.
Conclusions:
- Validated biomarkers for NAFLD progression and clinical utility are currently limited.
- Further investigation into the interplay between circadian regulation and hepatic metabolism may yield predictive biomarkers.
- Understanding these pathways is crucial for predicting liver disease progression and treatment outcomes.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...